Our data support a model in which the combination of a lack of early SARS-CoV-2 neutralization and an enhanced afucosylated IgG-CD16a signaling axis contribute to the inflammatory phenotype of severe COVID-19. This evidence concerns the gene FCGR3A and COVID-19.